Regenerative Medical Technology Group Inc. (RMTG)

Market Cap	376.17K
Revenue (ttm)	4.65M
Net Income (ttm)	-4.36M
Shares Out	12.54M
EPS (ttm)	-0.35
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	80,000
Average Volume	69,110
Open	0.0280
Previous Close	0.0280
Day's Range	0.0280 - 0.0300
52-Week Range	0.0210 - 0.0750
Beta	-0.13
RSI	40.45
Earnings Date	Aug 14, 2025

About Bally's

Regenerative Medical Technology Group Inc. operates in the regenerative medicine industry in the United States and internationally. It provides products, solutions, equipment, services, and training to doctors and their staff in the application of stem cell therapies. The company is also involved in the treatment of patients; provision of training and seminars; and resale of kits, products, equipment, and services. In addition, it offers reoccurring application of its process using its kits and solutions. The company was formerly known as Meso ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1999
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: RMTG

Financial Performance

In 2024, RMTG's revenue was $4.11 million, an increase of 70.44% compared to the previous year's $2.41 million. Losses were -$5.56 million, -43.31% less than in 2023.